This meeting will explore the next step in the evolution of genetic medicines with a discussion of therapies based on RNA. This will include an update on messenger RNA (mRNA) therapies and a broader discussion of the priorities of the industry. There will also be an exploration of technical issues such as the use of artificial intelligence for modelling and the modulation of RNA with small molecules.
